Evidence map›Paper›PMID 33532772›Full record

ArticlebioRxiv : the preprint server for biology2021

Skylar J Ferrara, Priya Chaudhary, Margaret J DeBell, Gail Marracci, Hannah Miller, Evan Calkins, Edvinas Pocius, Brooke A Napier, Ben Emery, Dennis Bourdette and 1 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Margaret J DeBell
Gail Marracci
Hannah Miller
Evan Calkins
Edvinas Pocius
Brooke A Napier
Dennis Bourdette
Thomas S Scanlan
Oregon Health & Science University · USPortland State University · US

Funding

Reprogramming of Inflammation, Immune Cell Function, and Disease Outcomes by the Western Diet (Supplement)R35GM133804 · NIGMS · PORTLAND STATE UNIVERSITY · PI NAPIER, BROOKE ANN · 2019 to 2023
$2.2M
NIGMS NIH HHS R35 GM133804
6 · The paper itself

Abstract

Triggering receptor expressed on myeloid cells-2 (TREM2) is a cell surface receptor on macrophages and microglia that senses and responds to disease associated signals to regulate the phenotype of these innate immune cells. The TREM2 signaling pathway has been implicated in a variety of diseases ranging from neurodegeneration in the central nervous system to metabolic disease in the periphery. We report here that

Identifiers

PMID33532772
PMCPMC7852265
OpenAlexW3123995634

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.